SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001461790-22-000022
Filing Date
2022-09-01
Accepted
2022-08-31 18:13:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 13G_TCRR_20220831.htm SC 13G 104738
  Complete submission text file 0001461790-22-000022.txt   106223
Mailing Address 2 BLOOR STREET WEST SUITE 801 TORONTO A6 M4W 3E2
Business Address 2 BLOOR STREET WEST SUITE 801 TORONTO A6 M4W 3E2 416-365-2155
K2 PRINCIPAL FUND, L.P. (Filed by) CIK: 0001461790 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 100 BINNEY STREET CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET CAMBRIDGE MA 02142 617-949-5200
TCR2 THERAPEUTICS INC. (Subject) CIK: 0001750019 (see all company filings)

IRS No.: 474152751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90936 | Film No.: 221219063
SIC: 2836 Biological Products, (No Diagnostic Substances)